4.6 Article

Prevalence of taste and smell dysfunction in mild and asymptomatic COVID-19 patients during Omicron prevalent period in Shanghai, China: a cross-sectional survey study

Related references

Note: Only part of the references are listed.
Article Pediatrics

The Emergence of Omicron: Challenging Times Are Here Again!

Tanu Singhal

Summary: COVID-19 has caused a significant number of cases and deaths worldwide, and the omicron variant is currently driving a surge in cases globally. Despite some protection provided by previous infection and vaccination, the impact of omicron on the healthcare system, economy, and children's health has been substantial. It is crucial for governments to make rational decisions to navigate through this crisis.

INDIAN JOURNAL OF PEDIATRICS (2022)

Letter Medicine, General & Internal

Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves

Caroline Maslo et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Chemistry, Medicinal

Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance

Jiahui Chen et al.

Summary: The Omicron variant of the SARS-CoV-2 virus has caused global panic due to its high infectivity and ability to escape vaccines. A comprehensive analysis using an artificial intelligence model and antibody structure analysis reveals that Omicron may be over 10 times more contagious than the original virus and has an 88% likelihood of vaccine escape. This study highlights the importance of developing mutation-proof vaccines and antibodies.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)

Article Virology

Characteristics of the first 1119 SARS-CoV-2 Omicron variant cases, in Marseille, France, November-December 2021

Linda Houhamdi et al.

Summary: Between November 28, 2021, and December 31, 2021, a total of 1119 cases of SARS-CoV-2 Omicron variant were diagnosed at the Institut Hospitalo-Universitaire Mediterranee Infection in Marseille, France. Among the 825 patients with known vaccination status, 46.4% were vaccinated, with 91.9% of them having received at least two doses of the vaccine. Interestingly, 26.3% of the cases developed SARS-CoV-2 infection within 21 days after the last dose of vaccine, suggesting early production of antibodies. There were 21 hospitalized patients, one in intensive care, and one patient who received a vaccine booster dose died.

JOURNAL OF MEDICAL VIROLOGY (2022)

Article Medicine, General & Internal

Prevalence of olfactory dysfunction and quality of life in hospitalised patients 1 year after SARS-CoV-2 infection: a cohort study

Hui Qi Mandy Tan et al.

Summary: This study aimed to investigate the long-term prevalence of olfactory and/or gustatory dysfunction in previously hospitalised patients with COVID-19, as well as the associated risk factors and impact on quality of life. The study found that 12.8% of patients still reported problems with smell or taste up to a year after infection, which had a negative impact on their quality of life, particularly their psychological well-being.

BMJ OPEN (2022)

Editorial Material Immunology

Omicron: a drug developer's perspective COMMENT

Fang Fang et al.

Summary: We annotated 35 mutations in the spike protein of the SARS-CoV-2 Omicron variant and found that it has gained significant immune evasion and potential for enhanced transmissibility. Previous modeling studies have suggested that continued evolution in immune evasion and enhanced transmissibility by SARS-CoV-2 could compromise the effectiveness of vaccines for pandemic control. To combat future variants of SARS-CoV-2, novel antiviral drugs are needed that can effectively curb viral spreading without introducing additional selective pressure towards resistant variants.

EMERGING MICROBES & INFECTIONS (2022)

Review Medicine, General & Internal

Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance

Shi-Yan Ren et al.

Summary: This review summarizes the highly mutated regions, infectivity, transmission, vaccine breakthrough, and antibody resistance of the SARS-CoV-2 variant Omicron. Omicron is highly transmissible and may cause milder symptoms. Vaccines are less effective against the Omicron variant.

WORLD JOURNAL OF CLINICAL CASES (2022)

Article Food Science & Technology

The COVOSMIA-19 trial: Preliminary application of the Singapore smell and taste test to objectively measure smell and taste function with COVID-19

Florence Sheen et al.

Summary: This study developed and tested a novel self-administered test to measure objective smell and taste losses associated with COVID-19. The study found that 36.2% of COVID-19 positive participants had objectively measured smell and/or taste loss. This is the first application of the test in a residential setting, providing a self-assessment tool for individuals with limited access to COVID-19 testing.

FOOD QUALITY AND PREFERENCE (2022)

Letter Public, Environmental & Occupational Health

The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta

Ying Liu et al.

JOURNAL OF TRAVEL MEDICINE (2022)

Article Otorhinolaryngology

A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss

Kathrin Ohla et al.

Summary: Sudden smell loss is a specific early symptom of COVID-19. A longitudinal survey on smell function and recovery reveals that while smell ability improves for many individuals during acute COVID-19, the prevalence of parosmia and phantosmia increases over time. Persistent smell impairment may be a key marker of long-term COVID-19 illness.

RHINOLOGY (2022)

Article Otorhinolaryngology

Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant

Paolo Boscolo-Rizzo et al.

Summary: The prevalence and severity of COVID-19-associated smell and taste dysfunction has significantly decreased with the advent of the Omicron variant but it still remains above 30%.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)

Article

Oral manifestations associated with COVID-19 disease: An observational cross sectional study

Jitendra Chawla et al.

Journal of Oral Biology and Craniofacial Research (2022)

Article Biochemistry & Molecular Biology

Article Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb

Mona Khan et al.

Summary: Anosmia, the loss of smell, is a common symptom of COVID-19, but it is caused by the virus attacking sustentacular cells in the olfactory mucosa rather than infecting olfactory sensory neurons. This suggests that SARS-CoV-2 is not a neurotropic virus.
News Item Multidisciplinary Sciences

HEAVILY MUTATED OMICRON VARIANT PUTS SCIENTISTS ON ALERT

Ewen Callaway

NATURE (2021)

Review Clinical Neurology

The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models

Rafal Butowt et al.

Summary: Recent studies suggest that the novel coronavirus may infect the brain through the olfactory nerve, causing loss of smell and taste. However, the current evidence for infection of olfactory neurons leading to brain infection is inconclusive, with conflicting results from animal and human studies. More research is needed to determine the exact mechanisms and routes of brain infection by SARS-CoV-2.

ACTA NEUROPATHOLOGICA (2021)

Review Biochemistry & Molecular Biology

The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia

Christopher S. von Bartheld et al.

Summary: The prevalence of chemosensory dysfunction in COVID-19 patients varies greatly between populations, possibly due to factors at the host and virus levels. The D614G mutation is identified as a major contributing factor to the increased prevalence of anosmia in COVID-19.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Otorhinolaryngology

Eight-month follow-up of olfactory and gustatory dysfunctions in recovered COVID-19 patients

Ameen Biadsee et al.

Summary: The study investigated recovery of loss of smell and taste among recovered COVID-19 patients, finding that complete recovery occurred in 52% and 61.5% for olfactory and gustatory functions, respectively, with dysfunction persisting in 48%-38.5% of patients. Gender did not significantly affect recovery, but patients who initially experienced olfactory dysfunction had lower recovery rates.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Article Infectious Diseases

Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults

Rosa Costa et al.

Summary: The study revealed that children have similar viral loads to adults, but may have a shorter duration of viral shedding.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Review Clinical Neurology

Post-viral effects of COVID-19 in the olfactory system and their implications

Michael S. Xydakis et al.

Summary: COVID-19 is often associated with olfactory dysfunction, providing a research opportunity to study the natural course of this neurological finding. However, limited by sample sizes and lack of advanced neuroimaging data, there is still a substantial gap in knowledge regarding the mechanisms of olfactory impairment. Persistent olfactory deficits post-SARS-CoV-2 infection could potentially be a marker for increased long-term risk of neurological disease.

LANCET NEUROLOGY (2021)

Article Oncology

Taste alterations and oral discomfort in patients receiving chemotherapy

Anne Kathrine Larsen et al.

Summary: This study found that 93% of cancer patients reported taste alterations, with patient age, oral discomfort, and swallowing difficulty identified as significant factors contributing to these alterations. However, no correlation was found between patients' acidity of saliva and taste alterations and oral discomfort.

SUPPORTIVE CARE IN CANCER (2021)

Article Dentistry, Oral Surgery & Medicine

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

Hao Xu et al.

INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)

Article Critical Care Medicine

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Zhe Xu et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Otorhinolaryngology

Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study

Eleonore Chary et al.

AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2020)

Article Otorhinolaryngology

Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19

Paolo Boscolo-Rizzo et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2020)

Article Otorhinolaryngology

Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms

Carol H. Yan et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2020)

Review Endocrinology & Metabolism

Factors leading to high morbidity and mortality ofCOVID-19 in patients with type 2 diabetes

Aman Rajpal et al.

JOURNAL OF DIABETES (2020)

Article Otorhinolaryngology

Xerostomia, gustatory and olfactory dysfunctions in patients with COVID-19

Paolo J. Fantozzi et al.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2020)

Article Medicine, General & Internal

Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients

Yonghyun Lee et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2020)

Article Endocrinology & Metabolism

Evaluation of olfaction and taste function in type 2 diabetic patients with and without peripheral neuropathy

Semih Yazla et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)

Article Neurosciences

Age-related changes of gustatory function depend on alteration of neuronal circuits

Emilia Iannilli et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2017)

Article Otorhinolaryngology

Psychometric validity of the 22-item Sinonasal Outcome Test

C. Hopkins et al.

CLINICAL OTOLARYNGOLOGY (2009)